β受体阻滞剂对A型主动脉夹层术后远期结局的影响
基于台湾全民健康保险研究数据库纳入2004至2013年4275例急性A型主动脉夹层手术修复患者,以出院后1年观察期判定β受体阻滞剂使用,经倾向评分匹配后每组396例分析。β受体阻滞剂组全因死亡风险(16.2% vs 23.7%;HR 0.65;95%CI 0.47-0.89)及主要心脑血管不良事件风险(19.2% vs 29.0%;HR 0.61;
要点
- A型主动脉夹层术后使用β受体阻滞剂与较低全因死亡风险相关(HR 0.65)。
- β受体阻滞剂使用与较低主要心脑血管不良事件风险相关(HR 0.61)。
核心结论
- β受体阻滞剂使用对急性A型主动脉夹层手术修复后患者的远期结局具有保护作用。
- 严格坚持β受体阻滞剂治疗与生存获益相关。
研究设计与样本
- 基于台湾全民健康保险研究数据库的观察性队列研究,纳入2004至2013年间接受手术修复的4275例急性A型主动脉夹层患者。
- 以出院后1年观察期判定β受体阻滞剂使用及用药依从性,β受体阻滞剂使用定义为1年内有药物处方,其余为非使用者。
- 采用倾向评分匹配分析,每组396例纳入分析。
主要发现
- β受体阻滞剂组全因死亡风险低于非β受体阻滞剂组(16.2% vs 23.7%;HR 0.65;95%CI 0.47-0.89)。
- β受体阻滞剂组主要心脑血管不良事件风险低于非β受体阻滞剂组(19.2% vs 29.0%;HR 0.61;95%CI 0.46-0.82)。
临床怎么用
- 对急性A型主动脉夹层手术修复后存活患者,应考虑使用β受体阻滞剂并强调严格用药依从性以改善远期预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of the study was to evaluate the effects of β-blocker therapy on long-term outcomes in patients after surgical repair of type A aortic dissection. METHODS: A total of 4275 patients with acute type A aortic dissection who underwent surgical repair between 2004 and 2013, were identified using the Taiwan National Health Insurance Research Database. A 1-year observational interval since discharge was used to determine β-blocker usage and medication adherence in survivors. β-Blocker usage was defined as medication prescription within 1 year. All others were defined as non-β-blocker users. Propensity score matching analysis was performed. The primary outcome was all-cause mortality. Secondary outcomes were major adverse cardiac and cerebral events, aortic reoperation, and readmission for any cause. RESULTS: A total of 396 patients of each group were deemed eligible for analysis. The risk of all-cause mortality was lower in the β-blocker group compared with the non-β-blocker group (16.2% vs 23.7%; hazard ratio, 0.65; 95% confidence interval, 0.47-0.89). The risk of major adverse cardiac and cerebral events was lower in the β-blocker group compared with the non-β-blocker group (19.2% vs 29.0%; hazard ratio, 0.61; 95% confidence interval, 0.46-0.82). Survival curves of β-blocker users were compared according to number of prescription days and showed that more days of β-blocker usage was associated with a lower risk of mortality (adjusted P for linear trend < .001). CONCLUSIONS: β-Blocker usage had a protective effect on long-term outcomes in patients after surgical repair of acute type A aortic dissection. Strict medication adherence of β-blocker therapy was associated with a survival benefit.
引用
- Chen SW, Lin YS, Wu VC, et al. Effect of β-blocker therapy on late outcomes after surgical repair of type A aortic dissection. J Thorac Cardiovasc Surg. 2019. PMID: 31262538. doi:10.1016/j.jtcvs.2019.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。